Q3 2016 Holdings
Filed 2016-11-10 | 20 holdings | $26.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $26.2M | 3,608,171 | 98.3% |
| Loxo Oncology Inc | COM | 548862101 | $105.5K | 4,028,920 | 0.4% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $63.1K | 1,609,727 | 0.2% |
| Cynapsus Therapeutics Inc. | COM | 23257Y859 | $45.1K | 1,121,381 | 0.2% |
| Aimmune Therapeutics Inc.(AIMT) | COM | 00900T107 | $44.9K | 2,990,000 | 0.2% |
| Viewray Inc.(VRAYQ) | COM | 92672L107 | $33.8K | 7,480,887 | 0.1% |
| Versartis Inc | COM | 92529L102 | $30.9K | 2,524,465 | 0.1% |
| Cempra Inc | COM | 15130J109 | $28.9K | 1,193,060 | 0.1% |
| Esperion Therapeutics Inc.(ESPR) | COM | 29664W105 | $22.7K | 1,637,125 | 0.1% |
| T2 Biosystems Inc | COM | 89853L104 | $20.5K | 2,830,992 | 0.1% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $15.9K | 2,275,455 | 0.1% |
| Transenterix Inc. | COM NEW | 89366M201 | $14.1K | 8,335,819 | 0.1% |
| Cidara Therapeutics Inc. | COM | 171757107 | $11.7K | 1,021,148 | 0.0% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $7.1K | 508,565 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $6.3K | 482,680 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $3.9K | 248,498 | 0.0% |
| Chimerix Inc.(CMRXEUR) | COM | 16934W106 | $2.6K | 472,943 | 0.0% |
| Pernix Therapeutics Hldgs in | COM | 71426V108 | $1.2K | 2,010,000 | 0.0% |
| Pernix Therapeutics Hldgs Inc | DEBT | 71426VAK4 | $675 | $2,500,000 | 0.0% |
| Lombard MED Inc | COM | G55598109 | $417 | 443,182 | 0.0% |